nafamostat has been researched along with seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ekblad, E; Sand, E; Themner-Persson, A | 1 |
| Andoh, T; Kuraishi, Y; Lee, JB; Tsujii, K; Ui, H | 1 |
| Akashi, R; Ishikura, H; Kawabata, A; Kitamura, T; Matsumura, K; Matsunami, M; Naruse, M; Nishimura, S; Sekiguchi, F; Shinozaki, Y | 1 |
3 other study(ies) available for nafamostat and seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide
| Article | Year |
|---|---|
Mast cells reduce survival of myenteric neurons in culture.
Topics: Animals; Benzamidines; Cell Count; Cell Survival; Cells, Cultured; Coculture Techniques; Dose-Response Relationship, Drug; Drug Interactions; Female; Guanidines; Histamine; Mast Cells; Myenteric Plexus; Neurons; Nitric Oxide Synthase; Oligopeptides; Proline; Rats; Rats, Sprague-Dawley; Serine Proteinase Inhibitors; Serotonin; Time Factors; Vasoactive Intestinal Peptide | 2009 |
Involvement of Tryptase and Proteinase-Activated Receptor-2 in Spontaneous Itch-Associated Response in Mice With Atopy-like Dermatitis.
Topics: Animals; Benzamidines; Chronic Disease; Dermatitis, Atopic; Disease Models, Animal; Dose-Response Relationship, Drug; Epidermal Cells; Epidermis; Guanidines; Keratinocytes; Male; Mast Cells; Mice; Oligopeptides; Protease Inhibitors; Receptor, PAR-2; Tryptases | 2009 |
The proteinase/proteinase-activated receptor-2/transient receptor potential vanilloid-1 cascade impacts pancreatic pain in mice.
Topics: Acute Disease; Animals; Benzamidines; Capsaicin; Ceruletide; Disease Models, Animal; Gene Expression Regulation; Guanidines; Hyperalgesia; Male; Mice; Oligopeptides; Pain; Pancreatitis; Proto-Oncogene Proteins c-fos; Receptor, PAR-2; Spinal Cord; TRPV Cation Channels | 2010 |